Prescriber's Corner

Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Derek Peterson, PharmD(c), and Joanna Schwartz, BCOP, PharmD

Albany College of Pharmacy and Health Sciences, Colchester, Vermont, and Fletcher Allen Healthcare, Burlington, Vermont

Derek Peterson, PharmD(c), 261 Mountain View Drive, Colchester, VT 05446. E-mail: derek.peterson@acphs.edu


J Adv Pract Oncol 2014;5:348–354 | DOI: 10.6004/jadpro.2014.5.5.5 | © 2014 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me